Natixis’s Tourmaline Bio TRML Stock Holding History

Natixis’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,700	Closed	-$894K	–	1306
2025 Q3	$894K	Buy	+18,700	New	+$519K	﹤0.01%	691

Natixis's TRML Position: Q4 2025 in Review

Natixis sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 18,700 shares — an estimated $894K sold.

Natixis first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $894K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Natixis reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Natixis sold 18,700 Tourmaline Bio shares in Q4 2025, an estimated $894K.
Natixis first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Natixis's Tourmaline Bio position peaked at $894K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.